Correlation Between Aslan Pharmaceuticals and IO Biotech
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and IO Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and IO Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and IO Biotech, you can compare the effects of market volatilities on Aslan Pharmaceuticals and IO Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of IO Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and IO Biotech.
Diversification Opportunities for Aslan Pharmaceuticals and IO Biotech
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aslan and IOBT is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and IO Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IO Biotech and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with IO Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IO Biotech has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and IO Biotech go up and down completely randomly.
Pair Corralation between Aslan Pharmaceuticals and IO Biotech
Given the investment horizon of 90 days Aslan Pharmaceuticals is expected to under-perform the IO Biotech. In addition to that, Aslan Pharmaceuticals is 1.51 times more volatile than IO Biotech. It trades about -0.35 of its total potential returns per unit of risk. IO Biotech is currently generating about -0.01 per unit of volatility. If you would invest 118.00 in IO Biotech on August 29, 2024 and sell it today you would lose (43.00) from holding IO Biotech or give up 36.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 27.2% |
| Values | Daily Returns |
Aslan Pharmaceuticals vs. IO Biotech
Performance |
| Timeline |
| Aslan Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| IO Biotech |
Aslan Pharmaceuticals and IO Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aslan Pharmaceuticals and IO Biotech
The main advantage of trading using opposite Aslan Pharmaceuticals and IO Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, IO Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IO Biotech will offset losses from the drop in IO Biotech's long position.| Aslan Pharmaceuticals vs. Monte Rosa Therapeutics | Aslan Pharmaceuticals vs. NewAmsterdam Pharma | Aslan Pharmaceuticals vs. Inventiva Sa | Aslan Pharmaceuticals vs. Cullinan Oncology LLC |
| IO Biotech vs. Pmv Pharmaceuticals | IO Biotech vs. Eliem Therapeutics | IO Biotech vs. MediciNova | IO Biotech vs. Pharvaris BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |